Bluesight for Controlled Substances launching the Diversion Collective, a New Educational Resource for Successful Diversion Prevention Programs.
Bluesight for Controlled Substances launching the Diversion Collective, a New Educational Resource for Successful Diversion Prevention Programs.
Bluesight for Controlled Substances launching the Diversion Collective, a New Educational Resource for Successful Diversion…
What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital?
What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital? By: Sandy Still, PharmD…
Drug Shortages, Variance Spikes and Other Key Takeaways from the Diversion Quarterly.
By Hannah Kanfer BluesightⓇ released the Q2 2022 Diversion Quarterly, sharing data from its…
ControlCheck™ Releases New Form Factor to Track Suppositories.
By Hannah Kanfer ControlCheck’s new release includes suppositories as the newest form factor. Customers…
Diversion Quarterly — Q2 2020
Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly…
A Pharmacist's Perspective: Automating Critical Tasks with David Vu
Dr. David Vu, PharmD, CPHIMS, PMP is a quality assurance engineer at Kit Check. He …
Using AI to Prevent Diversion, Improve Efficiency, and Ensure Safety
A recent Pharmacy Technology Report article highlighted how Kit Check partner Children’s Hospital of the …
Kit Check Hospital Pharmacy Operations Report Reveals Over a Third of Hospital Pharmacy Professionals Are Aware of at Least One Colleague Who Has Stolen Controlled Substances
Report shows diversion, shortages, and patient safety among top priorities for pharmacy personnel WASHINGTON (APRIL …
Diversion Quarterly — Q1 2020
Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly …
Premier Inc. Designates Kit Check as "Essential Business"
In this unprecedented time in America, especially in healthcare, we at Kit Check are honored …